Solid STAIRWAY Leads Roche To Phase III Study Of Faricimab In Wet AMD Trial
Executive Summary
Roche unveiled positive results from the Phase II STAIRWAY study which explored the extended durability of faricimab (RG7716) in the treatment of wet age-related macular degeneration (AMD).